全文获取类型
收费全文 | 74篇 |
免费 | 1篇 |
专业分类
妇产科学 | 1篇 |
临床医学 | 11篇 |
内科学 | 33篇 |
神经病学 | 1篇 |
特种医学 | 4篇 |
外科学 | 8篇 |
综合类 | 1篇 |
预防医学 | 15篇 |
药学 | 1篇 |
出版年
2022年 | 1篇 |
2021年 | 2篇 |
2020年 | 1篇 |
2019年 | 1篇 |
2018年 | 5篇 |
2017年 | 1篇 |
2016年 | 1篇 |
2014年 | 1篇 |
2013年 | 1篇 |
2012年 | 2篇 |
2011年 | 1篇 |
2010年 | 1篇 |
2009年 | 2篇 |
2008年 | 10篇 |
2007年 | 7篇 |
2006年 | 6篇 |
2005年 | 6篇 |
2004年 | 5篇 |
2003年 | 4篇 |
2002年 | 7篇 |
2001年 | 5篇 |
2000年 | 2篇 |
1998年 | 1篇 |
1975年 | 2篇 |
排序方式: 共有75条查询结果,搜索用时 19 毫秒
11.
Ronak Delewi Robin Nijveldt Alexander Hirsch Constantin B. Marcu Lourens Robbers Marriela E.C.J. Hassell Rianne H.A. de Bruin Jim Vleugels Anja M. van der Laan Berto J. Bouma René A. Tio Jan G.P. Tijssen Albert C. van Rossum Felix Zijlstra Jan J. Piek 《European journal of radiology》2012
Introduction
Left ventricular (LV) thrombus formation is a feared complication of myocardial infarction (MI). We assessed the prevalence of LV thrombus in ST-segment elevated MI patients treated with percutaneous coronary intervention (PCI) and compared the diagnostic accuracy of transthoracic echocardiography (TTE) to cardiovascular magnetic resonance imaging (CMR). Also, we evaluated the course of LV thrombi in the modern era of primary PCI.Methods
200 patients with primary PCI underwent TTE and CMR, at baseline and at 4 months follow-up. Studies were analyzed by two blinded examiners. Patients were seen at 1, 4, 12, and 24 months for assessment of clinical status and adverse events.Results
On CMR at baseline, a thrombus was found in 17 of 194 (8.8%) patients. LV thrombus resolution occurred in 15 patients. Two patients had persistence of LV thrombus on follow-up CMR. On CMR at four months, a thrombus was found in an additional 12 patients. In multivariate analysis, thrombus formation on baseline CMR was independently associated with, baseline infarct size (g) (B = 0.02, SE = 0.02, p < 0.001). Routine TTE had a sensitivity of 21–24% and a specificity of 95–98% compared to CMR for the detection of LV thrombi. Intra- and interobserver variation for detection of LV thrombus were lower for CMR (κ = 0.91 and κ = 0.96) compared to TTE (κ = 0.74 and κ = 0.53).Conclusion
LV thrombus still occurs in a substantial amount of patients after PCI-treated MI, especially in larger infarct sizes. Routine TTE had a low sensitivity for the detection of LV thrombi and the interobserver variation of TTE was large. 相似文献12.
13.
Nijveldt RJ Wiezer MJ Meijer C Prins HA Statius Muller MG Gouma DJ Teerlink T van Gulik TM Borel Rinkes IH Tilanus HW van de Velde CJ Wiggers T Zoetmulder FA Scotté M Cuesta MA Meijer S van Leeuwen PA 《Liver》2001,21(1):56-63
BACKGROUND/AIMS: Major liver resection results in a high morbidity and mortality, and endotoxin plays a role in post-resection hepatic failure. Severe hepatic failure as seen in hepatitis and cirrhosis may be accompanied by hepatic encephalopathy and is characterized by a typical plasma amino acid pattern reflected by a decreased Fischer ratio. This study was performed to evaluate the plasma amino acid pattern in patients undergoing major liver surgery receiving placebo or the endotoxin-neutralizing agent bactericidal/permeability-increasing protein (rBPI21). PATIENTS AND METHODS: Forty-eight patients were randomized in this phase II, dose escalation, multicenter trial. Plasma amino acid profiles were determined preoperatively, and on the first (day 1) and third (day 3) postoperative day. RESULTS: In the placebo group the Fischer ratio decreased significantly on both postoperative days. Administration of rBPI21 also resulted in a decreased Fischer ratio on day 1, but not on day 3. Highly elevated alanine plasma levels were observed on day 1 in placebo-treated patients, whereas rBPI21 prevented this elevation. Plasma alanine levels on day 1 correlated with the duration of post-resection hepatic failure. Conclusions: Major liver resection results in a decreased Fischer ratio and a rise in plasma alanine levels. Plasma levels of alanine on the first postoperative day correlated with the duration of the post-resection hepatic failure. rBPI21 improved the Fischer ratio and prevented the rise of plasma alanine levels. 相似文献
14.
15.
16.
Gladys N. Janssens Maarten A. H. van Leeuwen Nina W. van der Hoeven Guus A. de Waard Robin Nijveldt Roberto Diletti Felix Zijlstra Clemens von Birgelen Javier Escaned Marco Valgimigli Niels van Royen 《Journal of cardiovascular translational research》2016,9(3):249-256
Microvascular injury is present in a large proportion of patients with ST-elevation myocardial infarction (STEMI) despite successful revascularization. Ticagrelor potentially mitigates this process by exerting additional adenosine-mediated effects. This study aims to determine whether ticagrelor is associated with a better microvascular function compared to prasugrel as maintenance therapy after STEMI. A total of 110 patients presenting with STEMI and additional intermediate stenosis in another coronary artery will be studied after successful percutaneous coronary intervention (PCI) of the infarct-related artery. Patients will be randomized to treatment with ticagrelor or prasugrel for 1 year. FFR-guided PCI of the non-infarct-related artery will be performed at 1 month. Microvascular function will be assessed by measurement of the index of microcirculatory resistance (IMR) in the infarct-related artery and non-infarct-related artery, immediately after primary PCI and after 1 month. The REDUCE-MVI study will establish whether ticagrelor as a maintenance therapy may improve microvascular function in patients after revascularized STEMI. 相似文献
17.
18.
Robert J Nijveldt Michiel P C Siroen Tom Teerlink Antonie A van Lambalgen Jan A Rauwerda Paul A M van Leeuwen 《Liver international》2004,24(5):510-518
INTRODUCTION/AIM: Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide (NO) synthase enzymes, whereas symmetric dimethylarginine (SDMA) competes with arginine transport. Although both dimethylarginines may be important regulators of the arginine-NO pathway, their metabolism is largely unknown. In previous studies, evidence was found for the liver in the metabolism of dimethylarginines. We aimed to investigate dimethylarginine handling of the gut and the liver in detail under basal conditions and during endotoxemia. METHODS: Twenty-one male Wistar rats were used for this study. Endotoxemia was induced by lipopolysaccharide (LPS) infusion (8 mg/kg). Blood flow was measured using radiolabeled microspheres according to the reference sample method. Concentration of dimethylarginines were measured by high-performance liquid chromatography. The combination of arteriovenous concentration difference and organ blood flow allowed calculation of net organ fluxes and fractional extraction (FE) rates. RESULTS: Arterial plasma concentration of ADMA was lower in LPS rats, in contrast to a higher SDMA concentration. For the gut, net release of ADMA was found, which was higher in LPS rats. In contrast, for the gut, net uptake of SDMA was found, which was lower in LPS rats. For the liver, a high net uptake of ADMA was found in both groups, while FE was significantly increased in LPS rats. Hepatic handling of SDMA was negligible. CONCLUSION: The liver plays an important role in eliminating ADMA from the circulation and endotoxemia stimulates this capacity. In contrast to the liver, the gut releases ADMA. Endotoxemia results in a reduced systemic ADMA concentration. 相似文献
19.
Paul Knaapen Paolo G. Camici Koen M. Marques Robin Nijveldt Jeroen J. Bax Nico Westerhof Marco J. W. Götte Michael Jerosch-Herold Heinrich R. Schelbert Adriaan A. Lammertsma Albert C. van Rossum 《Basic research in cardiology》2009,104(5):485-498
Coronary microvascular dysfunction is a topic that has recently gained considerable interest in the medical community owing
to the growing awareness that microvascular dysfunction occurs in a number of myocardial disease states and has important
prognostic implications. With this growing awareness, comes the desire to accurately assess the functional capacity of the
coronary microcirculation for diagnostic purposes as well as to monitor the effects of therapeutic interventions that are
targeted at reversing the extent of coronary microvascular dysfunction. Measurements of coronary microvascular resistance
play a pivotal role in achieving that goal and several invasive and noninvasive methods have been developed for its quantification.
This review is intended to provide an update pertaining to the methodology of these different imaging techniques, including
the discussion of their strengths and weaknesses. 相似文献
20.
Nijveldt RJ Siroen MP van der Hoven B Teerlink T Prins HA Girbes AR van Leeuwen PA 《European journal of clinical nutrition》2004,58(4):587-593
OBJECTIVE: In physiological conditions, the liver plays an important role in the regulation of plasma arginine concentrations by taking up large amounts of arginine from the hepatic circulation. When hepatic failure is present, arginine metabolism may be disturbed. Therefore, we hypothesized high arginine plasma concentrations in critically ill patients suffering from hepatic failure. DESIGN: We prospectively collected blood samples from a cross-section of intensive care unit patients. SETTING: Surgical intensive care unit of a Dutch university medical center. SUBJECTS: A total of 52 critically ill patients with clinical evidence of dysfunction of more than two organs were recruited. MEASUREMENTS: Plasma arginine concentrations were determined by HPLC. We identified correlations of arginine concentrations with organ failure scores and laboratory variables by univariate and multiple regression analyses. RESULTS: High plasma arginine concentrations were found in critically ill patients developing organ failure. Patients who were in the highest quartile of plasma arginine concentrations had significantly lower fibrinogen concentrations, higher lactic acid concentrations, and longer prothrombin time. Stepwise multiple regression analysis showed that concentrations of arginine were independently associated with the presence of hepatic failure (P=0.03) and renal failure (P=0.048). In addition, lactic acid proved to be an independent determinant of plasma arginine concentration (P=0.014). CONCLUSIONS: Critically ill patients who suffer from hepatic failure have elevated plasma arginine concentrations. Additional arginine in the treatment of these patients can be harmful, and therefore should not be used as a standard nutritional regimen until further evaluation. 相似文献